Jason Pontin is a General Partner at DCVC (Data Collective), where he joined in 2021 after serving as a Senior Partner. See sector focus and contact routes.
Jason Pontin is a General Partner at DCVC (Data Collective), where he joined in 2021 after serving as a Senior Partner at Flagship Pioneering and previously leading *MIT Technology Review* as Editor in Chief from 2004 to 2017. His investment thesis focuses on early-stage computational biology, chemistry, and deep tech startups that address intractable diseases, accelerate scientific discovery, and transform inefficient industries into sustainable sectors. He typically invests at pre-seed, seed, and Series A stages with check sizes ranging from $5 million to $25 million, often acting as a lead investor. Notable portfolio companies include Totus Medicines, which he co-founded and is a founding board member of, as well as Menten.AI, Kanvas Biosciences, and Relation Therapeutics. Pontin distinguishes himself through his dual background as a venture capitalist and prominent journalist, having written for *Wired*, *The New York Times*, and *The Economist* while serving on multiple life sciences and hard tech boards. He actively helps portfolio companies communicate their stories, leveraging his media expertise to amplify their impact.
Details on this investor come from filing and round data held in the StartupFundraising directory, refreshed on ingest. Founders use profiles like this one to qualify fit and to shortlist investors in Boston.
Investors like Jason Pontin · Full investor directory · Investor access · Company funding database